Endonovo Therapeutics, Inc. (ENDV)
OID · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardio chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular, and peripheral artery disease (PAD) and ischemic stroke. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.
Peers in Healthcare
Endonovo Therapeutics, Inc. has no peer companies in this window.
Recent press releases
Endonovo Therapeutics, Inc. has not issued a press release in this window.
SEC filings
All filings →Endonovo Therapeutics, Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →Endonovo Therapeutics, Inc. has no reported insider trades in the last 90 days.
Institutional holders
All holders →People at Endonovo Therapeutics, Inc.
All people →No officers or directors have been indexed for Endonovo Therapeutics, Inc..
Quarterly financials
Full financials →No quarterly financials have been ingested for Endonovo Therapeutics, Inc..